Apollo Gleneagles Hospital, Kolkata

Details Associates
Medical Suppliers In West Bengal

Name :

Apollo Gleneagles Hospital, Kolkata

Address  :

58, Canal Circular Road

Town  :

Kolkata

State  :

West Bengal

Country  :

INDIA

Post Code:

700 054

Phone  :

91 33 2320 3040

Fax  :

91 33 2320 5218

Web URL  :

Available

Email  :

hospital@apollogleneagles.in
Specialization
  • Cardiology
  • Dermatology
  • ENT
  • Gastro-enterology
  • Neuro Surgeon
  • Neurologist
  • Obestetrician/Gynecologist
  • Oncologist
  • Ophthalmology
  • Orthopedics
  • Urology
Facilities

Total Number Of Beds : 510

Speciality Type :

Other Facilities

  • Pathology
  • X-Ray
  • CT/MRI
Description
Apollo Gleneagles Hospitals Kolkata
A 425bedded multispecialty tertiary care hospital Apollo Gleneagles Hospitals Kolkata is a perfect blend of technological excellence complete infrastructure competent care and heartfelt hospitality this is how the people whom we have been fortunate to serve define the hospital

Apollo Gleneagles Hospitals is a joint venture of Apollo Group of Hospitals India and Parkway Health of Singapore

The Parkway Group is a leading healthcare group in Asia It provides more than 70 of private healthcare in Singapore Its subsidiaries include Parkway Group Healthcare which owns a network of regional hospitals and medical centers in Malaysia India and Brunei and Parkway Hospitals Singapore which owns three hospitals in Singapore East Shore Gleneagles Mount Elizabeth Hospitals and Parkway Health Day surgery Centre
NEWS
6 swine flu cases in city hospitals put on high alert

NEW DELHI H1N1 influenza is back With six cases confirmed in the capital Delhi government has put all government hospitals on alert and directed them to follow the H1N1 protocol including having an isolation ward with dedicated staff at select centres Two of these cases were recently confirmed by the National Centre for Disease Control senior h... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More